Skip to content

Effect of 7 Days of Grape Seed Extract Supplementation on Cold Pressor Test and Muscle Metaboreflex in Individuals With Elevated and Stage 1 Hypertension

Effect of 7 Days of Grape Seed Extract Supplementation on Cold Pressor Test and Muscle Metaboreflex in Individuals With Elevated and Stage 1 Hypertension

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06428890
Enrollment
12
Registered
2024-05-24
Start date
2022-03-01
Completion date
2024-04-01
Last updated
2024-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prehypertension

Brief summary

This study aimed to assess the effect of the supplementation with grape seed extract (GSE) on blood pressure during static handgrip exercise and muscle metaboreflex in individuals with elevated and state 1 hypertension.

Detailed description

Muscle metatoreflex (MMR) has been known to play an important role in adjusting hemodynamic responses during exercise. The reflex increases sympathetic activity to heart and blood vessels to increase blood supply to contracting skeletal muscles. On the other hand, studies demonstrated that abnormal cardiovascular responses occurred by the overactive MMR in pathological conditions such as hypertension, diabetes, and congestive heart failure. Excessive blood pressure (BP) responses to exercise induce cardiovascular events such as stroke, heart attack, and coronary artery disease. Previously, a study found that dietary supplementation with grape seed extract (GSE) reduced BP response to dynamic exercise in individuals with elevated and stage 1 hypertension (ES1H) and associated with peripheral vasodilation. However, mechanisms underlying this phenomenon are not clear. Purpose: therefore, the purpose of this study is to investigate whether chronic dietary supplementation with GSE can decrease BP responses to exercise and this observation is associated with reduced MMR. Methods: 12 ES1H males were studied. Changes in cardiac output (Q), mean arterial pressure (MAP) and total peripheral resistance (TPR) were compared between the GSE and placebo supplementations during static handgrip exercise (SHE) and post exercise muscular ischemia (PEMI). Participants completed 3 min of SHE at 40% of MVC followed by 2 min of PEMI.

Interventions

DIETARY_SUPPLEMENTGrape Seed Extract

dietary supplements that rich in polyphenolic compounds

DIETARY_SUPPLEMENTPlacebo

Starch

Sponsors

California Baptist University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
MALE
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* systolic blood pressure: 120-139 mmHg and/or a diastolic blood pressure: 80-89 mmHg

Exclusion criteria

* taking medications that could affect cardiovascular function or BP

Design outcomes

Primary

MeasureTime frameDescription
heart rate (bpm)5 minutes, 3 minutes, and 2 minutes, respectively.measured these variables at rest and during static handgrip exercise and muscle metaboreflex
stroke volume (ml)5 minutes, 3 minutes, and 2 minutes, respectively.measured these variables at rest and during static handgrip exercise and muscle metaboreflex
cardiac output (l/min)5 minutes, 3 minutes, and 2 minutes, respectively.measured these variables at rest and during static handgrip exercise and muscle metaboreflex
systolic blood pressure (mmHg)5 minutes, 3 minutes, and 2 minutes, respectively.measured these variables at rest and during static handgrip exercise and muscle metaboreflex
diastolic blood pressure (mmHg)5 minutes, 3 minutes, and 2 minutes, respectively.measured these variables at rest and during static handgrip exercise and muscle metaboreflex
total peripheral resistance (mmHg/l/min)5 minutes, 3 minutes, and 2 minutes, respectively.measured these variables at rest and during static handgrip exercise and muscle metaboreflex

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026